Higher levels of CRP and BFP were associated with an increased risk of incident T2D (all p for trend <.001), a one‐SD increase in CRP levels (1.1 mg/L) was associated with a 40% increase in the risk of incident T2D (95% CI: 37%–42%), and a one‐SD increase in BFP (8.5%) was associated with a 69% increase in the risk of incident T2D (95% CI: 64%–75%). This evidence concerns the gene CRP and type 2 diabetes mellitus.